Candida vulvovaginitis epidemiology and demographics

Revision as of 21:51, 18 October 2016 by Dima Nimri (talk | contribs)
Jump to navigation Jump to search

Candidiasis Main page

Patient Information

Overview

Causes

Classification

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]

Overview

Candida vulvovaginitis is not a reportable disease and epidemiological studies on the prevalence of the disease are hard to perform.

Epidemiology and Demographics

Epidemiological studies on Candida vulvovaginitis are hard to perform, because of several factors:[1][2]
1. Candida vulvovaginitis is not a reportable disease
2. The diagnosis of Candida vulvovaginitis is based on clinical presentation, as well as positive laboratory findings. Relying on a positive culture alone would likely overestimate the prevalence of Candida vulvovaginitis
3. The use of over-the-counter (OTC) topical anti-fungals makes epidemiological studies harder to perform

References

  1. Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR (1998). "Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations". Am. J. Obstet. Gynecol. 178 (2): 203–11. PMID 9500475.
  2. Sobel JD (2007). "Vulvovaginal candidosis". Lancet. 369 (9577): 1961–71. doi:10.1016/S0140-6736(07)60917-9. PMID 17560449.


Template:WH Template:WS